Marek TrněnýExecutive Steering Committee Member

Professor Marek Trněný is a Professor of Medical Oncology and Head of the First Faculty of Medicine at Charles University Hospital, Prague, CZ. He graduated from the Faculty of General Medicine at Charles University, Prague, CZ, in 1985, and until 1989 he worked at the Institute of Chemical Technology, Prague, CZ. Since 1990, Prof. Trněný has worked at the General Teaching Hospital and the First Faculty of Medicine and has completed his residency and fellowship in internal medicine, hematology, and medical oncology. In January 2008, he was appointed Head of the First Internal Clinic of the General Teaching Hospital and First Faculty of Medicine at Charles University, and he was appointed as Professor of Medical Oncology in 2009.

Prof. Trněný’s professional focus is on the pathogenesis and targeted treatment of lymphoma and chronic lymphocytic leukemia, including hematopoietic stem cell transplantation. He has authored and co-authored more than 170 research papers and reviews, and has participated either as principal investigator or sub-investigator in more than 30 clinical trials within the field of hematology.

Positions of responsibility/awards:

• Founding member of Czech Lymphoma Study Group, and chair since 2004
• Executive board member of Czech Society of Hematology since 1998
• Coinvestigator of the European Mantle Cell Lymphoma Network
• Member of Lymphoma Scientific Working Group of the European Hematology Association (EHA)
• Member of the European Society for Medical Oncology (ESMO) Educational Committee for hematologic tumors
• Member of the American Society of Hematology (ASH)
• Head of Lymphoma group and Stem Cell Transplantation program at the General Hospital, Charles University, Prague, CZ